CLINICAL AND HISTOPATHOLOGICAL INVESTIGATION OF IVERMECTIN TOXICITY IN PIGEONS. Waleed M. S.

Similar documents
Summary of Product Characteristics

Summary of Product Characteristics

Drug therapy of Filariasis. Dr. Shareef sm Asst. professor pharmacology

For the treatment and prevention of infections caused by:

Cydectin. Fort Dodge PRODUCT DESCRIPTION

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I. Marketing Authorisation Holder (Name and address): Reference Member State:

SUMMARY OF THE PRODUCT CHARACTERISTICS

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

MOXIDECTIN SPOT-ON SOLUTION FOR KITTENS AND SMALL CATS. 280 mg/ml FLURALANER 14 mg/ml MOXIDECTIN Also contains: 339 mg/ml DIMETHYLACETAMIDE (solvent)

SUMMARY OF PRODUCT CHARACTERISTICS

A Parasiticide for the Treatment and Control of Internal and External Parasites of Cattle and Swine

SUMMARY OF PRODUCT CHARACTERISTICS. Milprazon 16 mg/40 mg film-coated tablets for cats weighing at least 2 kg

SUMMARY OF PRODUCT CHARACTERISTICS. Equimax Tabs Vet, 150 mg / 20 mg, Chewable tablet for Horses

SUMMARY OF PRODUCT CHARACTERISTICS

Efficacy of abamectin against gastrointestinal nematodes in calves

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

SUMMARY OF THE PRODUCT CHARACTERISTICS

Please refer to Table 1 Dosage and Treatment Schedule TABLE 1 Species Product Number of Tubes Cats. Rabbits or Advantage 40 for Cats

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: Imidacloprid 40 mg/pipette (0.4 ml of a 10 % solution)

SUMMARY OF PRODUCT CHARACTERISTICS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

SUMMARY OF PRODUCT CHARACTERISTICS. Equest Oral Gel, 18,92 mg/g, Oral Gel for Horses and Ponies

Summary of Product Characteristics

Fluralaner (mg) for small cats kg for medium-sized cats > kg for large cats > kg 1.

For the treatment of mixed parasitic infections in cats caused by roundworms and tapeworms of the following species:

discover the nextgeneration of flea & tick protection NEW TASTY CHEW ONE CHEW ONCE A MONTH

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

In cattle: For the treatment of infections with the following parasites

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

A Survey of Dermatophytes Isolated from Cows and Sheep in Iraq

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

McKeever Dermatology Clinics

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

European Public MRL assessment report (EPMAR)

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX III LABELLING AND PACKAGE LEAFLET

SUMMARY OF PRODUCT CHARACTERISTICS

MARBOCYL 10% SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

DISSOCIATIVE ANESTHESIA

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Meningeal worm (deer, brain worm) Parelaphostrongylus tenuis by Dr. Mary Smith DVM & Dr. tatiana Stanton

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

MARBOCYL FD SUMMARY OF PRODUCT CHARACTERISTICS

US Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Procedure # IBT IACUC Approval: December 11, 2017

your dog Protect UP TO $50 AND SAVE COME SEE US TO [City, ST ZIP] [Street Address] [First Name Last Name] [Phone Number] [City, ST ZIP]

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

The Reconsideration of Approvals and Registrations Relating to FIPRONIL

COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE

Health Products Regulatory Authority

SOP #: Page: 1 of 6 Rodent Analgesia

INTRODUCTION TO WILDLIFE PHARMACOLOGY. Lisa Fosco Wildlife Rehabilitation Manager Toronto Wildlife Centre

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

SURGICAL TREATMENT OF EAR HAEMATOMA IN DOGS Mohsin Abdul Jalil Falih ABSTRACT

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

Pain Management in Racing Greyhounds

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

SHE SINGS ALONG TO EVERY SONG...

SUMMARY OF PRODUCT CHARACTERISTICS

Cydectin Pour-On for Cattle

Summary of Product Characteristics

Incredible. xng237353_techdetailer4thtick9x12_rsg.indd 1

UPDATE ON THE DIAGNOSIS AND MANAGEMENT OF DEMODICOSIS

DOSE TITRATION, EFFICACY AND SAFETY OF DROP ON IVERMECTIN FOR THE MANAGEMENT OF KNEMIDOCOPTES SPP INFESTATION IN BUDGERIGARS.

COMPARATIVE VERTEBRATE HISTOLOGY ZOO 4756c Syllabus for Fall 2018

SUMMARY OF PRODUCT CHARACTERISTICS. Milprazon 2.5 mg/25 mg Tablets for Small Dogs and Puppies Weighing At Least 0.5 kg

IS THE USE OF DCR-1339 HUMANE? Prof. Joan Dawes

European public MRL assessment report (EPMAR)

SUMMARY OF PRODUCT CHARACTERISTICS

Saunders Solutions in Veterinary Practice Small Animal Dermatology by Anita Patel and Peter Forsythe 2008 Elsevier Ltd. All rights reserved.

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Summary of Product Characteristics

Summary of Product Characteristics

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

4.5. Special precautions for use Special precautions to be taken by person administering the veterinary medicinal product to animals

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Mosquitoes & Diseases. Maxwell Lea, Jr. DVM State Veterinarian Louisiana Dept. of Agriculture and Forestry Department of Animal Health Services

N.C. A and T List of Approved Analgesics 1 of 5

Metacam 1.5 mg/ml oral suspension for dogs

Push flea protection forward

1.3.1 Milbemycin oxime + Praziquantel SPC, Labeling and Package Leaflet GB

Transcription:

CLINICAL AND HISTOPATHOLOGICAL INVESTIGATION OF IVERMECTIN TOXICITY IN PIGEONS Waleed M. S. Department of Pathology, College of Veterinary University of Basrah, Basrah, Iraq. Keywords; liver, kidney, ivermectin. (Received 23 November 2009, Accepted 14 December 2009) ABSTRACT The aim of this study was to investigate the clinical signs and histopathological changes of acute toxicity of ivermectin in the centeral and peripheral nervous system liver, kidney, pancreas and heart of pigeons after s/c injection with ivermectin.eighteen bird were divided into three equal groups.group A were injected with 8mg,group B were injected with 10 mg and group C served as control group.the results showed markedy reduced of water and food consumption,somnolence and death of treated pigeons.nervous signs were restlessness, ataxia, un steady gait, tremor and recumbent. The histopathological changes included degeneration of nerve fibers of spinal cord and sciatic nerve.degeneration, necrosis and vacuolation were noticed in liver, kidney and heart,as wll as proliferation of bile duct was also seen in liver. INTRODUCTION Ivermectin is an antiparasites medication and is it effective against most common intestinal worms,most mice and som lice.while normaly used to treat animals,it is also prescribed to human to treat infestation of srongyloides stercoralis.(1). It is effective against all kinds of internal and external live stock and poultry parasites,including internal parasites such as nematode,pinworm,filarial,trichinella spiralisand external parasites such as mite, louse, tick, flea, fly, maggot, larva, used in rabbit, chickens, goose, cat, fox and other wild animals.it has good clinical efficacy to treatment of pig scabies rabbit scabies,ring worm and scabies of rabbit,chickens knee mite,(2).it is slso used to treat internal parasites (Ascaridia galli ) of infected white leghorn chicks at dose of 0.3-1mg/kg bw for 10 and 35 days. Ivermectin exert their anti-parasitic activity via the activation of glutamate-gated chloride channel present un the invertebrate nerve and muscle cells(4,5), and /or trough the effect on gamma amino butyric acid (GABA) receptors(4,6,7),leading to paralysis and death of target organisms.in the vertebrates, ivermectin can produce GABA-mimetic effect agonist 130

at GABA receptors,stimulating the release of GABA, or through other mechanisms(6,8,9).mammals,however,are less susceptible to the toxic effects of ivermectin because GABA-mediated nervous occure in the nervous system (CNS) and ivermectin do not ready cross the blood brain barrier(bbb;6). Ivermectin is a semi-synthetic derivative of one of the avermectins, a groupm of macrocyclic lactones produced by the soil bacterium Streptomyces avermitilis(10).peneteration of the blood brain barriers occurs in releatively high doses,with brain levels peaking between two and five hours after administration.symptomas seen in a range of mammalian species are CNS depression,consequent ataxia,as might be expected from potentiation of inhibitory GABA-ergic synapse(11). Aim of this study was to investigate the clinical signs and histopathological changes of acute toxicity of ivermectin of pigeons. MATERIALS AND METHODS Rock dove pigeons(culumba livia) purchased from local market in basrah province,with average body weight of (250-400)gm were used in this study.they were reared in cages (100x100x 80) in poultry unit /at the college of veterinary medicine Basrah university.and treated with ivermectin after 7 days of their rearing. Primary trails were conducted to determine the maximum tolerated dose through using different doses till reaching 8mg and 10 mg/kg body weight of ivermectin. Eighteen birds were divided into three groups,group A were injected s/c with 8mg /bird of ivermectin,while birds in group B injected s/c with 10 mg of ivermectin and the group C served as control group.clinical signs were recorded.tissue samples were taken from spinal cord,sciatic nerve,liver,pancreas and kidney to study the histopathological changes Representative tissue samples were taken and fixed in 10 neutral buffered formalin.after prolonged washing in tap water the sections of tissues were dehyderated in ascending grades of alcohol and then cleared in xylin. Paraffin section of 5 μm thickness,were cut and stained with heamatoxylin and eosin(13). A-Clinical signs Clinical sings of RESULTS AND DISCUSSION ivermectin toxicity included ataxia,sedation,tremor,coma,somnolence and listlessness were developed 4 hours post s/c injection of 8 mg ivermectin /kg bw.five bird of group A were deaed after 48 hour of dosing.these results in the line with that of (14) who mentioned the same clinical signs in falcon(falco rusticolus).the group B exihibited more sever clinical signs than that of group A.All bird of group B were died after 131

40 hour of dosing with 10 mg ivermectin /kg bw. The same results were recorded in chickens (15). These results attributed to high doses of ivermectin or mutation in p-glycoprotein which can allow ivermectin to pass through the blood brain barrier to cause neurotoxicity in animals (15), manifesting diarrhea,depression,ataxia,coma, tremor and death(16,17). In this study the signs of ataxia,tremors,sedation,somnolence and coma were in agreement with (18) who observed that the feed and water consumption were markedly reduced.bradypnea,ataxia,sedation,coma and death occurred with the highest dose of ivermectin in chickens.this result was in line with that of (16) who recorded that dose releated toxicity was also found in chickens, Ivrmectin,given ton rat IV at dose of 4 mg /kg produced moderate incoordination ;6 mg /kg induced a state rresembling anaesthesia which began one minute after injection and lasted for four to five hours.higher doses caused death in most type of animals due to respiratory depression (11).Four of eight dog given 2mg /kg/day developed tremors,ataxia,anorexia and become dehydrated (12). B-Histopathological examination; Pigeons injected s/c with 8 mg of ivermectin were showed histopathological changes either in peripheral nerve (sciatic nerve ) or in spinal cord as degenerate nerve fiber of both,these results conflicted with(15) who did not report any histological cganges in chickens.young animals are generally more sensitive to the toxicity of ivermectin.a kitten was reported to exhibit toxicosis afterb receiving subcutaneous administration of 0.3 mg/kg ivermectin(7).animals deficient in p-glycoprotein a component of the blood brain barrier are also more sensitive to ivermectin toxicity than animals with normal p-glycoprotein level(14,15).solvents and additives of commercial avermectins (hexanol,butylated hydroxytoluene) may enhance the toxicity as well(19).adverse effects of ivermectin therapy are not un common and most of them appear within 48 hour of initiating therapy(20,21.22). The present study revealed,area of hepatic necrosis in group B and hepatic cell degeneration with marked vacuolation of hepatocytes in group A.These results were in disagreement with those of(15) who did not report any histological changes in chicken injected s/c with ivermectin. This may be explained by the fact that pathway and primarily ivermectin is metabolized in the liver via oxidative, and excreted in the feces while less than 5% of ivermectin is excreted in the urine. A very large numbers of etiological agents are capable of causing necrosis such as medications (23). 132

The study revealed,no evidence of effect of ivermectin in the pancreas. The results revealed,vacuolation of renal cortical tubules.the present study exhibited bile duct proliferation and dilatation and congestion of artery in myocardial muscles.these results were in disagreement with that of (15).There is no previous study releated to this work. Fig.(1) Group A. Sciatic nerve. Longitudinal section. degenerate and vacuolated nerve fibersx200 Fig. (2): Group B. Sciatic nerve.longitudinal section. Vacuolated and degenerate nerve fibers.x200. 133

Fig.(3) Group A Spinal cord. Longitudinal section.degenerate and vacuolated nerve fibers x200 Fig(4) Group B. liver.transverse section. degeneration X200 134

Liver.Transvers section. necrosis X200. Fig(5):Group A. Fig.(6):Group B. Liver.transverse section. necrosis. X200. 135

Fig. (7) Group B. Liver.portal vein dilatation, Bile duct proliferation.x200 Fig. (9) Group A. Liver. Transverse section a- Congestion b- haemrorrhage. Periportal fibrosis with inflammatory cells. X800. 136

Fig(10) Group A.Pancreas.longitudnal section. Exocrine and endocrine. There is no evidence of effect on exocrine or endocrine part of the pancrease. X200. Fig(11): (Group A)Heart-myocardial muscle. Congested artery.x200. 137

Fig(12): Group A. Kidney. Transverse section. vaculation of renal cortical tubules.200x دراسة سريريه و نسجية هرضية للتسون بااليفرهكتين في الحوام. ون ذ يج ذ صكر فرع األيراض وأيراض انذواج - كه ح انطة انث طري - جايعح انثصرج - انثصرج انعراق الخالصة كا انهذف ي انذراضح هى ذقص انعالياخ انطر ر ح وانرغ راخ ان رض ح ان طج ح نهرط ى انحاد تاال فريكر ف انجهاز انعصث ان ركسي وان ح ط و انكثذ وانكه ح وانث كر اش وانقهة ف انح او تعذ حقة اال فريكر ذحد انجهذ. قط د 18 ط را انى ثالثح يجاي ع يرطاو ح. حق د ان خ ىعح ا 8 يهغى,ت ا حق د ان ج عح ب 10 يهغى,اذخذخ ان ج ىعح ش ك ج ىعح ض طرج.اوضحد ان رائج ا خفاض واضح ف اضرهالك انعهف وان اء وانخ ىل ويىخ انح او ان عايم.كا د انعالياخ انعصث ح :انرر ح وان ش ح غ ر ان رس ح وانرعشح وانرقىد. ذض د انرغ راخ ان طج ح ان رض ح ذ كص االن اف انعصث ح نهحثم انشىك وانعصة انىرك. نىحظ انر كص و انر خر و انرفج ف انكثذ وانكه ح وا ضا ذكاثر انق اج انصفراء. 138

REFERENCES 1-Edwards G,Breckenridge Am (1995.)Clinical pharmacokinetic of anthelmintic drugs. Veterinary Parasitology;N;15.P;67-93 2-Button C,Barton R,Hony P,RickfordP. (1988) Ivermectin toxicity in calves and an evaluation of picrotoxin as an antidote. Aust.vet.j..95:157-158. 3-Sharma RL,Bhat TK,Hemaprasanth. (1990) Anthelmintic activity of ivermectin against experimental Ascaridia galli infection in chickens. 37;3-4. 4- Burkhart CN. (2000); Ivermectin: an assessment of its pharmacology, microbiology and safety. Vet. Hum.Toxicol N;42: P;30-35. 5- Cully DF, Vassilatis DK, Liu KK, et al. (1994) Cloning of avermectin sensitive glutamategated chloride channel from caenorhabditis elegans. Nature371:707-711. 6-Campell.WC, Fisher MH, Stapley EO, et al. (1983) Ivermectin: a potent antiparasitic agent. Science;221 7- Roder JD, Stair EL. ( 1998) An overview of ivermectin toxicosis. Vet 8- Ette EI, Thomas WO, Achumba JI.(1990). Ivermectin: a long-acting microfilaricidal agent.;24:426-33. 9-Dawson GR, Wafford KA, Smith A, et al. (2000) Anticonvulsant and adverse effects of avermectins analogs in mice are mediated through the g-aminobutyric acida receptor. J. Pharmacol Exp Ther;295:1051-60 10- Campbell WC & Benz GW (1984) Ivermectin: a review of efficacy and safety. J. Vet Pharma Ther,N; 7: 1-16 11- Hayes WJ & Laws ER (1991) Handbook of pesticide toxicology. Vol 2. Classes of pesticides. Academic Inc, San Diego, California, p; 1576. 12- MSD (Merck Sharp & Dohme) (1988) Poison Control Monograph. ivermectin. Division of Merck & Co Ltd, West Point, Pennsylvania, 18 pp ivermectin. Division of Merck & Co Ltd, West Point, Pennsylvania p; 18. 13-Luna, L..G.(1968).Munal of histological staining method of the armed institute of pathology.3 rd edition.mc Graw.Hill book.co.london. 14- M. Lierz MR 2001). Evaluation of the dosage of ivermectin in falcons.the Veterinary Record, Vol 148, Issue 19, P;596-600 15- Kim EC. (1995) Clinical signs of ivermectin toxicity and the efficacy of antigabaergic convulsants as antidote for ivermectin poisoning in epileptic chickens. Vet. Hum. Toxicol.; N;37: P;122-6 139

16. Agarwal AK: Avermectin. In Wexler P (eds): (1998) Encyclopedia of Toxicology, 1st ed. San Diego: Academic Press,: p;89-90 17-. Lankas GR, Cartwright ME, Umbenhauer D. (1997) P-Glycoprotein deficiency in a subpopulation of CF-1 mice enhances avermectin-induced neurotoxicity. Toxicol Appl Pharmacol; vol;143: p.357-65 18-Shoop WL, Mrozik H, Fisher MH. (1995)Structure and activity of avermectins and milbemycins in animal health. Vet Parasitol;59: p;139-156 19-. Hsu DZ, Hsu CH, Huang BM, et al. (2001) Abamectin effects on aspartate aminotransferase and nitric oxide in rats. Toxicology ;165:189-93. 20-De Sole G, Remme J, Awadz K, et al. (1989) Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull World Health Org;67: p;707-19 21.Chung K, Yang CC, Wu ML, et al.( 1999) Agricultural. avermectins: an uncommon but potentially fatal cause of pesticide poisoning. Ann Emerg Med 34: p;51-7. 22-Donald C.Plumb.(1991).Veterinary drughandbook ;.University of Minnesota. 23-Hafidh A,Omad A.(1999).Veterinary pathology handbook.ministery of higher education and scientific research. University of mosul. 140